Results 111 to 120 of about 1,253,166 (338)

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

open access: yesmedRxiv, 2020
Summary Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated.
Juanjuan Zhao   +24 more
semanticscholar   +1 more source

The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS‐CoV‐2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort Study

open access: yesAdvanced Science, EarlyView.
Azvudine shows benefits in reducing all‐cause mortality in hospitalized SARS‐CoV‐2 infected patients and liver diseases. COVID‐19 patients with kidney disease and without autoimmune diseases show a preference for azvudine. Azvudine may be a promising antiviral agent for treating COVID‐19 concomitant with liver diseases.
Junyi Sun   +18 more
wiley   +1 more source

Coronavirus Update 4-13-2021 [PDF]

open access: yes, 2021
We have some good news for you. Since our COVID numbers have continued to be stable following the long Easter weekend, we are going to loosen some of our campus restrictions over these final weeks of the ...
The Coronavirus Planning Team,
core   +1 more source

Coronavirus biology and replication: implications for SARS-CoV-2

open access: yesNature Reviews Microbiology, 2020
The SARS-CoV-2 pandemic and its unprecedented global societal and economic disruptive impact has marked the third zoonotic introduction of a highly pathogenic coronavirus into the human population.
P. V’kovski   +4 more
semanticscholar   +1 more source

T‐Cell‐Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS‐CoV‐2 Infection

open access: yesAdvanced Science, EarlyView.
This study describes the development of spike‐targeting T‐cell‐dependent bispecific full‐length human immunoglobulin Gs with enhanced efficacy in the treatment of COVID‐19. The significance of T‐cell‐based immunity during infection is highlighted. These results have significant implications for better clinical effectiveness of therapies for COVID‐19 ...
Wenyan Fu   +8 more
wiley   +1 more source

Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality

open access: yesBrain and Behavior, Volume 12, Issue 12, December 2022., 2022
Abstract Background Little is known about risk factors for mortality in older patients with COVID‐19 and neuropsychiatric conditions. Methods We conducted a multicentric retrospective observational study at Assistance Publique‐Hôpitaux de Paris. We selected inpatients aged 70 years or older, with COVID‐19 and preexisting neuropsychiatric comorbidities
Vi‐Huong Nguyen‐Michel   +23 more
wiley   +1 more source

Coronavirus Update 12-18-2020 [PDF]

open access: yes, 2020
As we conclude the semester, the dashboard shows us with 63 active cases. During the break, we will be updating the dashboard weekly on Thursdays.
The Coronavirus Planning Team,
core   +1 more source

Coronavirus Update 11-16-21 [PDF]

open access: yes, 2021
We want to take a moment to thank you and congratulate you for the attention you have paid to the Pioneer Promise this semester. As a result, our COVID numbers have been low (as of today we have one active case in our community) and we have been able to ...
The Coronavirus Planning Team,
core   +1 more source

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

open access: yesRadiology, 2020
In this retrospective study, chest CTs of 121 symptomatic patients infected with coronavirus disease-19 (COVID-19) from four centers in China from January 18, 2020 to February 2, 2020 were reviewed for common CT findings in relationship to the time ...
Adam Bernheim   +13 more
semanticscholar   +1 more source

Advancing the Identification of Bioactive Molecules and the Construction of a Synergistic Drug Delivery System in Combating Lung Injury

open access: yesAdvanced Science, EarlyView.
Traditional Chinese Medicine (TCM), while holistic and historically esteemed, faces challenges in “miracle cures” due to slow onset, long cycles, and difficulty controlling quality. This study obtains the active ingredients, glabridin (GLA) and puerarin (PUE), from Ge‐Gen Decoction (GGD), developing a safe and effective drug delivery system, GLA‐PUE ...
Jianhong Qi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy